Indexes of von Willebrand Factor as Biomarkers of Aortic Stenosis Severity (from the Biomarkers of Aortic Stenosis Severity [BASS] Study)

被引:40
|
作者
Blackshear, Joseph L. [1 ]
Wysokinska, Ewa M. [2 ]
Safford, Robert E. [1 ]
Thomas, Colleen S. [3 ]
Stark, Mark E. [4 ]
Shapiro, Brian P. [1 ]
Ung, Steven [1 ]
Johns, Gretchen S. [5 ]
Chen, Dong [6 ]
机构
[1] Mayo Clin Florida, Div Cardiovasc Dis, Jacksonville, FL 32224 USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Mayo Clin Florida, Biostat Unit, Jacksonville, FL USA
[4] Mayo Clin Florida, Div Gastroenterol & Hepatol, Jacksonville, FL USA
[5] Mayo Clin Florida, Dept Lab Med & Pathol, Jacksonville, FL USA
[6] Mayo Clin, Div Hematopathol, Rochester, MN USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2013年 / 111卷 / 03期
关键词
ECHOCARDIOGRAPHIC-ASSESSMENT; DISEASE; FLOW; CARDIOMYOPATHY; MANAGEMENT; DIAGNOSIS; IMPACT;
D O I
10.1016/j.amjcard.2012.10.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We correlated von Willebrand factor (VWF) activity indexes and brain natriuretic peptide (BNP) with measures of aortic stenosis (AS) severity, bleeding, symptoms, and freedom from death or aortic valve replacement. Patients with AS (n = 66 [16 mild, 20 moderate, and 30 severe]) and aortic valve replacement (n = 21) were assessed with VWF antigen, VWF latex agglutination immunoturbidic activity, platelet function analyzer collagen plus adenosine diphosphate (PFA-CADP), VWF multimer ratio, and BNP level after echocardiography. In patients with AS, the mean gradient correlated with BNP (Spearman r = 0.29, p = 0.02), VWF latex agglutination immunoturbidic activity/VWF antigen ratio (r = -0.41, p<0.001), PFA-CADP (r = 0.49, p<0.001), and VWF multimer ratio (r = -0.76, p<0.001). The area under the curve for detection of severe AS was 0.62 (95% confidence interval [CI] 0.48 to 0.77) by elevated BNP, 0.81 (95% CI 0.69 to 0.92) by PFA-CADP closure time, 0.69 (95% CI 0.55 to 0.82) by VWF latex agglutination immunoturbidic activity/VWF antigen ratio, and 0.86 (95% CI 0.76 to 0.95) by VWF multimer ratio. For the VWF multimer ratio, a threshold of 0.15 yielded a sensitivity and specificity for severe AS of 77% and positive predictive value of 74%. Bleeding (in 14%) was associated with a prolonged PFA-CADP time and reduced VWF latex agglutination immunoturbidic activity/VWF antigen ratio. Symptoms were associated with elevated BNP and low Duke Activity Status Index score. In 66 patients with AS, freedom from death (n = 4) or aortic valve replacement (n = 22) was associated with PFA-CADP (p = 0.003), VWF high-molecular/weight multimers (p = 0.009), and VWF latex agglutination immunoturbidic activity/VWF antigen ratio (p<0.001) but not BNP (p = 0.32). In severe AS versus aortic valve replacement, the PFA-CADP and VWF multimer ratio differed (p<0.001), but BNP and the VWF latex agglutination inununoturbidic activity/VWF antigen ratio did not. In conclusion, the VWF activity indexes were associated with AS severity and bleeding and were predictive of cardiovascular outcomes. (C) 2013 Elsevier Inc. All rights reserved. (Am J Cardiol 2013;111:374-381)
引用
收藏
页码:374 / 381
页数:8
相关论文
共 50 条
  • [1] Biomarkers of Aortic Stenosis Severity
    Blackshear, Joseph L.
    Safford, Robert E.
    Ung, Steven
    Misiri, Juna
    Johns, Gretchen S.
    Mufuka, Gabriel B.
    Parikh, Pragnesh P.
    Al-Omari, Malik A.
    Chen, Dong
    CIRCULATION, 2011, 124 (21)
  • [2] Assessment of exercise-induced changes in von Willebrand factor as a marker of severity of aortic stenosis
    Zelis, Jo M.
    Zimmermann, Frederik M.
    Andriessen, Froukje P. J.
    Houthuizen, Patrick
    Van de Ven, Jop
    Leuverman, Jolanda
    Johnson, Nils P.
    Pijls, Nico H. J.
    Scharnhorst, Volkher
    Van't Veer, Marcel
    Tonino, Pim A. L.
    OPEN HEART, 2020, 7 (01):
  • [3] Aortic stenosis, von Willebrand factor, and bleeding
    Williams, RC
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (18): : 1773 - 1774
  • [4] Aortic stenosis, von Willebrand factor, and bleeding
    Sadler, JE
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (04): : 323 - 325
  • [5] von Willebrand factor in patients with aortic stenosis
    Goodall, HM
    Cowell, SJ
    Boon, NA
    Newby, DE
    Ludlam, CA
    Dawson, P
    Germain, L
    Wallace, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 16 - 16
  • [6] The incidence and severity of aortic plaque in patients with aortic stenosis and its relation with severity of aortic stenosis
    Nishimura, S.
    Izumi, C.
    Imanaka, M.
    Kuroda, M.
    Amano, M.
    Imamura, S.
    Onishi, N.
    Tamaki, Y.
    Enomoto, S.
    Miyake, M.
    Tamura, T.
    Kondo, H.
    Kaitani, K.
    Nakagawa, Y.
    EUROPEAN HEART JOURNAL, 2016, 37 : 148 - 148
  • [7] Aortic stenosis and haemorrhagic syndrome: close correlation between severity of AS and acquired abnormalities of von Willebrand factor
    Le Tourneau, T
    Six, I
    Susen, S
    Fabre, O
    Juthier, F
    Caron, C
    Jude, B
    Vincentelli, A
    EUROPEAN HEART JOURNAL, 2002, 23 : 598 - 598
  • [8] Aortic stenosis, von Willebrand factor, and bleeding - Reply
    Susen, S
    Vincentelli, A
    Jude, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (18): : 1774 - 1774
  • [9] SEVERITY OF AORTIC-STENOSIS
    VOELKEL, AG
    PARISI, AF
    CHEST, 1981, 79 (02) : 252 - 252
  • [10] SEVERITY OF AORTIC-STENOSIS
    SPODICK, DH
    CHEST, 1981, 79 (01) : 122 - 122